RFRobin Farias-Eisner

Robin Farias-Eisner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Robin Farias-Eisner has a total of 71 co-authors. Here are the top co-authors by number of shared publications:

  • Holly Stessman

    37 Creighton University School of Medicine, Omaha, NE, United States

    2 shared publications
  • Jay Vadgama

    39 Creighton University School of Medicine; Charles Drew University; David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, CA, United States

    2 shared publications
  • John Joseph Coté

    Department of Obstetrics and Gynecology, Creighton University School of Medicine, Omaha, NE, USA; CommonSpirit Health, Omaha, NE, USA

    2 shared publications
  • Srinivasa Tadiparthi Reddy

    Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90747, USA

    2 shared publications
  • Yanyuan Wu

    38 Creighton University School of Medicine; Charles Drew University; David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, CA, United States

    2 shared publications
  • Adrienne Perfilio Edwards

    12 Creighton University School of Medicine, Omaha, NE, United States

    1 shared publication

Latest Publications

  • Serum Interleukin-6 Levels in Endometriosis and Endometriosis-Associated Ovarian Cancer: A Systematic Review and Meta-Analysis Demonstrating a Biological Gradient

    by John J. Coté, Remington D. Coté, Keara Kennedy, Matthew S. Block, Robin Farias-Eisner, Ryan W. Walters, Lesley B. Conrad

  • Endometriosis: A Malignant Fingerprint

    by Christopher DeAngelo, Megan Burnett Tarasiewicz, Athena Strother, Heather Taggart, Caron Gray, Meaghan Shanahan, Christopher Glowacki, Jimmy Khandalavala, Erin Talaska, Andrea Kinnan, et al.

    Endometriosis is complex, but identifying the novel biomarkers, inflammatory molecules, and genetic links holds the key to the enhanced detection, prediction and treatment of both endometriosis and endometriosis related malignant neoplasia. Here we review the literature relating to the specific molecular mechanism(s) mediating tumorigenesis arising within endometriosis. Guidance (e.g. Cochrane) and published studies were identified. The Published studies were identified through PubMed using the systematic review methods filter, and the authors’ topic knowledge. These data were reviewed to identify key and relevant articles to create a comprehensive review article to explore the molecular fingerprint associated with in endometriosis-driven tumorigenesis. An important focus is the link between C3aR1, PGR, ER1, SOX-17 and other relevant gene expression profiles and endometriosis-driven tumorigenesis. Further studies should also focus on the combined use of CA-125 with HE-4, and the role for OVA1/MIA as clinically relevant diagnostic biomarkers in the prediction of endometriosis-driven tumorigenesis. Elucidating endometriosis’ molecular fingerprint is to understand the molecular mechanisms that drive the endometriosis-associated malignant phenotype. A better understanding of the predictive roles of these genes and the value of the biomarker proteins will allow for the derivation of unique molecular treatment algorithms to better serve our patients.


  • Open Access

    COVID-19 and a novel initiative to improve safety by 3D printing personal protective equipment parts from computed tomography

    by John J. Coté, John Haggstrom, Ranuga Vivekanandan, Kristin A. Coté, Daniel L. Real, David P. Weber, Anne Cheng, Nicholas G. Dubay, Robin Farias-Eisner

    Background: Powered air-purifying respirators are in short supply and can break down with extended use. Replacement parts can become hard to acquire. The aim of this study was to create an innovative quality improvement proof of concept using rapid prototyping.Methods: Here we report three cases of 3D printed powered air-purifying respirator parts. 3D printing was performed on all parts using fused deposition modeling with standard polylactic acid, in the same way that presurgical models would be created. Measurements using an electronic caliper as well as CT scans were used to compare an original part to its corresponding 3D printed parts for accuracy.Results: Electronic caliper and computed tomography measurements both showed accuracy consistant with current published norms.Conclusions: Ultimately, there will be questions surrounding intellectual property, effectiveness and potential long-term safety for these types of 3D printed parts. Future research should look into the addition of specific nanoparticles from the position of cost, efficacy, safety and improved accuracy.


  • Open Access

    Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Develop- ment in Mice

    by Feng Su, Anantharamaiah Gm, Mayakonda N. Palgunachari, C. Roger White, Holly Stessman, Yanyuan Wu, Jay Vadgama, Richard Pietras, Dorothy Nguyen, Srinivasa T. Reddy, et al.

    Treatment of Metastatic Sweat Gland Carcinomas: Response in Two Cases Journal of Cancer Research and Therapeutic Oncology aims at rapid publication of high quality results in cancer research which are open access.


  • Open Access

    A Novel HDL-Mimetic Peptide HM-10/10 Protects RPE and Photoreceptors in Murine Models of Retinal Degeneration

    by Feng Su, Christine Spee, Eduardo Araujo, Eric Barron, Mo Wang, Caleb Ghione, David R. Hinton, Steven Nusinowitz, Ram Kannan, Srinivasa T. Reddy, et al.

    Age-related macular degeneration (AMD) is a leading cause of blindness in the developed world. The retinal pigment epithelium (RPE) is a critical site of pathology in AMD. Oxidative stress plays a key role in the development of AMD. We generated a chimeric high-density lipoprotein (HDL), mimetic peptide named HM-10/10, with anti-oxidant properties and investigated its potential for the treatment of retinal disease using cell culture and animal models of RPE and photoreceptor (PR) degeneration. Treatment with HM-10/10 peptide prevented human fetal RPE cell death caused by tert-Butyl hydroperoxide (tBH)-induced oxidative stress and sodium iodate (NaIO3), which causes RPE atrophy and is a model of geographic atrophy in mice. We also show that HM-10/10 peptide ameliorated photoreceptor cell death and significantly improved retinal function in a mouse model of N-methyl-N-nitrosourea (MNU)-induced PR degeneration. Our results demonstrate that HM-10/10 protects RPE and retina from oxidant injury and can serve as a potential therapeutic agent for the treatment of retinal degeneration.